Livanova earnings were $63.2M for the trailing 12 months ending Dec 31, 2024, with 254.5% growth year over year. The latest LIVN earnings report on Dec 31, 2024 announced Q4 2024 earnings of $55.9M, up 69.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LIVN reported annual earnings of $63.2M, with 260.4% growth.
LIVN past earnings growth
How has LIVN's earnings growth performed historically?
On LIVN's earnings call on Invalid Date, Livanova (NASDAQ: LIVN) reported Q4 2024 earnings per share (EPS) of $1.03, up 232.26% year over year. Total LIVN earnings for the quarter were $55.89 million. In the same quarter last year, Livanova's earnings per share (EPS) was $0.31.
As of the last Livanova earnings report, Livanova is currently profitable. Livanova's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $63.23 million, a 260.39% increase year over year.
What was LIVN's earnings growth in the past year?
As of Livanova's earnings date in Invalid Date, Livanova's earnings has grown 254.55% year over year. This is 206.06 percentage points higher than the US Medical Devices industry earnings growth rate of 48.48%. LIVN earnings in the past year totalled $63.23 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.